Pharmaceuticals, Biotechnology and Life Sciences
Continued R&D progress on two candidate programs representing novel mechanism of action Strengthens team with addition of industry veteran, Michael…
Finch & Takeda to target Crohn’s disease under expanded collaboration SOMERVILLE, Mass.–(BUSINESS WIRE)–Finch Therapeutics Group, Inc. (“Finch”) and Takeda Pharmaceutical…
ATHENS, Ga. & RESEARCH TRIANGLE PARK, N.C.–(BUSINESS WIRE)–Aruna Bio, Inc., a leader in the development of neural exosomes for the…
– ZEPHYR study successfully recruits over 150 patients in eight months for Phase 2b portion of pivotal Phase 2b/3 study…
BEDFORD, Mass.–(BUSINESS WIRE)–Verseau Therapeutics, Inc. today announced the appointment of Tim Smith as chief business officer. In this newly created…
– BT5528 targets EphA2, an antigen believed to be overexpressed in tumor types with high unmet need and a target…
PALO ALTO, Calif.–(BUSINESS WIRE)–LifeMax Laboratories, Inc. (“LifeMax”), a private company focused on treating rare diseases with few or no therapeutic…
TORONTO & GARCHING, Germany–(BUSINESS WIRE)–Two partnership agreements signed today will lay the groundwork for a new isotope delivery system at…
Simulation-first approach provides deeper understanding of cancer cells, and supports rational decision-making to unlock new treatments Company’s first institutional funding…
LONDON–(BUSINESS WIRE)–#ALLERGAN–The global asthma spacers market size is poised to grow by USD 297.72 million during 2019-2023, according to a…